Management of Pterygium Dr VIDYASHANKAR G K Shekar

  • Slides: 18
Download presentation
Management of Pterygium Dr VIDYASHANKAR G K Shekar Nethralaya Bangalore 1 12/2/2020

Management of Pterygium Dr VIDYASHANKAR G K Shekar Nethralaya Bangalore 1 12/2/2020

Pterygium Defn : An Elastotic Degenerative condition of conjunctiva with a wing like encroachment

Pterygium Defn : An Elastotic Degenerative condition of conjunctiva with a wing like encroachment of conjunctiva on to the Cornea. Pathogenesis – Ø Environmental causes- UV exposure, dust heat , wind exposure Ø Heredity Ø Coroneo Effect -Nasal segment of cornea gets highest UV exposure effect Ø Limbal Stem cell defect with Fibroblast Activation 2 12/2/2020

Pterygium - Classification Ø Primary Pterygium Body Neck Ø Recurrent Pterygium Head Ø Atrophic

Pterygium - Classification Ø Primary Pterygium Body Neck Ø Recurrent Pterygium Head Ø Atrophic Pterygium Older pts, thin translucent body with thin vessels Ø Pogressive Pterygium Thick fleshy growth seen in Younger pts 3 12/2/2020

Pterygium Grading of pterygium helps for management Depending on Size. Grade 1 Grade 2

Pterygium Grading of pterygium helps for management Depending on Size. Grade 1 Grade 2 Grade 3 Variants ü Cystic degeneration ü Bidirectional ü Pseudo pterygium – present anywhere, neck bridges limbus 4 12/2/2020

Pterygium- Management Ø Observation Asymptomatic , grade 1 pterygium Ø Medical Management Symptomatic Grade

Pterygium- Management Ø Observation Asymptomatic , grade 1 pterygium Ø Medical Management Symptomatic Grade 1 and 2 pterygium Eye drops – Tear substitutes, Decongestants Local injections – anti VEGFs, Steroid Ø Surgical Management 5 12/2/2020

Pterygium -Surgical Management IndicationsØ Symptomatic patients - recurrent irritation, redness and watering Ø Visual

Pterygium -Surgical Management IndicationsØ Symptomatic patients - recurrent irritation, redness and watering Ø Visual need - covering visual axis or threatening visual axis - causing irregular astigmatism - Grade 2 and 3 Pterygium Ø Cosmetic Ø Therapeutic - suspected associated neoplastic degeneration - motility restriction 6 12/2/2020

Pterygium -Surgical Management Different Procedures have been described Ø Excision - Bare sclera technique

Pterygium -Surgical Management Different Procedures have been described Ø Excision - Bare sclera technique Ø Excision and direct suturing of cut ends of conjunctiva Ø Excision of Head +Rotation and burial of body in inferior fornix Ø Excision + Conj Auto graft (CAG) - most preferred Ø Excision + MMC + Conj Auto graft Ø Excision + AMG + Conj Auto graft Ø Excision + MMC + AMG + Conj Auto graft For recurrent pterygium Ø Excision + Conjunctivolimbal Auto graft 7 12/2/2020

Pterygium -Surgical Management Excision Either from medial conjunctival side or from head Peeling off

Pterygium -Surgical Management Excision Either from medial conjunctival side or from head Peeling off pterygium from corneal surface Smoothening of Corneal surface with 15 no Blade or diamond Burr Conjuntiva sutured with 8 -0 Vicryl suture Limbal apposition - can be done by 10 -0 nylon Monofilament suture 8 12/2/2020

Pterygium -Surgical Management Adjuvants – to reduce recurrence Mitomycin C- For recurrent pterygia Intra

Pterygium -Surgical Management Adjuvants – to reduce recurrence Mitomycin C- For recurrent pterygia Intra op or post op Uncommonly used Late Scleral necrosis & melt Thiotepa – used post op Beta radiation with Strontium 90 High complications Excimer Laser in PTK mode – for corneal smoothening 9 12/2/2020

Pterygium- Surgical Complications ü Graft contration ü Recurrence ü Graft edema ü Corneal scaring

Pterygium- Surgical Complications ü Graft contration ü Recurrence ü Graft edema ü Corneal scaring ü Graft necrosis ü Ocular motility restriction ü Granuloma formation ü Surgical induced Necrotising ü Excessive cautery- scleral necrosis ü Infection 10 Scleritis (SINS) 12/2/2020

Pterygium- Surgical Complications Graft contraction – insufficient size of graft - more chance for

Pterygium- Surgical Complications Graft contraction – insufficient size of graft - more chance for granuloma - watch for recurrence Graft edema – almost all cases at 1 wk post op - no intervention - can be associated with Dellen formation Graft necrosis – if graft is placed upside down ( reverse) 11 12/2/2020

Pterygium- Surgical Complications Recurrence – most common complication -More in Young pts, -Surgery for

Pterygium- Surgical Complications Recurrence – most common complication -More in Young pts, -Surgery for progressive & recurrent perygium -In bare sclera method Granuloma – more common -with bare sclera technique -in young patients - can be seen at donor site also ® - increase Steroids - excision if no response 12 12/2/2020

Pterygium- Surgical Complications Sterile Surgical induced Necrotising Scleritis (SINS) -more common with MMC usage

Pterygium- Surgical Complications Sterile Surgical induced Necrotising Scleritis (SINS) -more common with MMC usage - systemic work up for Autoimmune vasculitic disorders - steroids in high dosage - long term systemic immunosuppression - may need Scleral Patch Graft Excessive cautery. Scleral necrosis in Bare sclera method No inflammation, no pain AMG or Conj graft 13 12/2/2020

Pterygium- Surgical Complications Ocular motility restriction – - Extensive excision causing Symblepharon formation -

Pterygium- Surgical Complications Ocular motility restriction – - Extensive excision causing Symblepharon formation - Intra op Medial Rectus muscle damage - Diplopia in post op period Corneal scaring – - Poor visual acuity and quality of vision due to irregular astigmatism - PTK Excimer laser may help 14 12/2/2020

Pterygium- Surgical Complications Microbial Infection - rare - Identify organism - culture and sensitivty

Pterygium- Surgical Complications Microbial Infection - rare - Identify organism - culture and sensitivty - antibiotics / antifungals 15 12/2/2020

Pterygium - Management Recent Advances Local Injections Ø Anti VEGF agents- Bevacizumab (Avastin) 0.

Pterygium - Management Recent Advances Local Injections Ø Anti VEGF agents- Bevacizumab (Avastin) 0. 25 mg (0. 1 ml) For both primary & recurrent pterygia Ø Steroids –Triamcinolone Acetonide (0. 1 ml- 2 mg) For recurrent pterygia 16 12/2/2020

Pterygium - Management Recent Advances Fibrin Glue Tisseal glue (Baxter Pharma) use for Ø

Pterygium - Management Recent Advances Fibrin Glue Tisseal glue (Baxter Pharma) use for Ø Conj Auto graft & Amniotic membrane fixation Ø Less Surgical time Ø Less post op irritation Ø Faster recovery Ø ? More recurrence 17 12/2/2020

THANK YOU 18 12/2/2020

THANK YOU 18 12/2/2020